John R. Garrett

Chief Executive Officer at Glycosyn LLC

Health Technology

Profile

John R.
Garrett is currently the Co-Chief Executive Officer at Glycosyn LLC and the Executive Director at Glycosyn Health Initiatives, Inc. He previously worked as a Director at Advanced Proteome Therapeutics Corp.

John R. Garrett active positions

Companies	Position	Start
Glycosyn LLC Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett.	Chief Executive Officer	-
Glycosyn Health Initiatives, Inc.	Director/Board Member	-

All active positions of John R. Garrett

Former positions of John R. Garrett

Companies	Position	End
ADVANCED PROTEOME THERAPEUTICS CORPORATION	Director/Board Member	-

See the detail of John R. Garrett's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John R. Garrett's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ADVANCED PROTEOME THERAPEUTICS CORPORATION	Health Technology

Private companies	2
Glycosyn LLC Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett.	Health Technology
Glycosyn Health Initiatives, Inc.